Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.

Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.

BACKGROUND/AIM: The mode of action of the somatostatin analog octreotide on neuro-endocrine tumour proliferation is largely unknown. Overexpression of the proto-oncogene Akt/PKB (protein kinase B) has been demonstrated in certain neuro-endocrine tumours: Akt activates downstream proteins including...

Полное описание

Библиографические подробности
Главные авторы:	Grozinsky-Glasberg, S, Franchi, G, Teng, M, Leontiou, C, Ribeiro de Oliveira, A, Dalino, P, Salahuddin, N, Korbonits, M, Grossman, AB
Формат:	Journal article
Язык:	English
Опубликовано:	2008

Схожие документы

Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
по: Druce, MR, и др.
Опубликовано: (2009)

The Rapamycin Derivative RAD001 (Everolimus) Inhibits Cell Proliferation and Interacts with the Akt-mTOR-p70S6K Pathway in Human Medullary Thyroid Carcinoma Cells
по: Grozinsky-Glasberg, S, и др.
Опубликовано: (2009)

The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells.
по: Grozinsky-Glasberg, S, и др.
Опубликовано: (2010)

Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors
по: Yim K-L
Опубликовано: (2012-07-01)

Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma.
по: Michael K Kiessling, и др.
Опубликовано: (2016-01-01)

Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas.
по: Keiko Shoji, и др.
Опубликовано: (2012-01-01)

Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
по: Dworakowska, D, и др.
Опубликовано: (2009)

RAD001 enhances the potency of BEZ235 to inhibit mTOR signaling and tumor growth.
по: Beat Nyfeler, и др.
Опубликовано: (2012-01-01)

The Global mTOR Inhibitor Torin1 Is More Effective than the mTORC1 Inhibitor, Everolimus, Alone or in Combination with Histone Deacetylase Inhibitors, in Suppressing Neuroendocrine Tumor Cell Proliferation
по: Grozinsky-Glasberg, S, и др.
Опубликовано: (2011)

Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients
по: Mathis Wehming, и др.
Опубликовано: (2023-02-01)

Correction: Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma.
по: Michael K Kiessling, и др.
Опубликовано: (2017-01-01)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
по: Zhilin Zou, и др.
Опубликовано: (2020-03-01)

Effects of Resveratrol, Lovastatin and the mTOR-Inhibitor RAD-001 on Insulin-Induced Genomic Damage In Vitro
по: Eman Awad, и др.
Опубликовано: (2017-12-01)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
по: Victor H. Villar, и др.
Опубликовано: (2017-05-01)

Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus
по: Micol Silic-Benussi, и др.
Опубликовано: (2023-03-01)

mTOR, autophagy and reprogramming
по: Bor Luen eTang
Опубликовано: (2014-01-01)

Plasticity and mTOR: Towards Restoration of Impaired Synaptic Plasticity in mTOR-Related Neurogenetic Disorders
по: Tanjala T. Gipson, и др.
Опубликовано: (2012-01-01)

AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1
по: George K. E. Umanah, и др.
Опубликовано: (2022-08-01)

Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity
по: Gigin Lin, и др.
Опубликовано: (2018-08-01)

mTOR Signalling, Nutrients and Disease
по: Goberdhan, D, и др.
Опубликовано: (2008)

The mTOR pathway in the antiphospholipid syndrome
по: Ji Lanlan, и др.
Опубликовано: (2023-12-01)

mTOR Signaling in Metabolism and Cancer
по: Shile Huang
Опубликовано: (2020-10-01)

The Translational Regulation in mTOR Pathway
по: Miaomiao Yang, и др.
Опубликовано: (2022-06-01)

Overview of Research into mTOR Inhibitors
по: Beibei Mao, и др.
Опубликовано: (2022-08-01)

Targeting ganglioneuromas with mTOR inhibitors
по: Ting Tao, и др.
Опубликовано: (2021-01-01)

Targeting mTOR for cancer therapy
по: Hui Hua, и др.
Опубликовано: (2019-07-01)

Successful treatment with the mTOR inhibitor everolimus in a patient with Perivascular epithelioid cell tumor
по: Gennatas Constantine, и др.
Опубликовано: (2012-09-01)

Activated mTOR signaling pathway in myofibers with inherited metabolic defect might be an evidence for mTOR inhibition therapies
по: Jing-Wei Lyu, и др.
Опубликовано: (2019-04-01)

Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models
по: Chun-Ting Kuo, и др.
Опубликовано: (2019-07-01)

mTOR inhibition by everolimus in childhood acute lymphoblastic leukemia induces caspase-independent cell death.
по: Rana Baraz, и др.
Опубликовано: (2014-01-01)

Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells
по: Sarah Bernard, и др.
Опубликовано: (2021-12-01)

mTOR Signaling in Growth Control and Disease
по: Laplante, Mathieu, и др.
Опубликовано: (2014)

An emerging role of mTOR in lipid biosynthesis
по: Laplante, Mathieu, и др.
Опубликовано: (2012)

mTOR Signaling in Growth, Metabolism, and Disease
по: Saxton, Robert Andrew, и др.
Опубликовано: (2018)

The mTOR pathway and integrating immune regulation.
по: Cobbold, S
Опубликовано: (2013)

The effects of mTOR inhibition in ischemic stroke
по: Schneider, AM
Опубликовано: (2022)

mTOR Dysregulation, Insulin Resistance, and Hypertension
по: Silviu Marcel Stanciu, и др.
Опубликовано: (2024-08-01)

mTOR Inhibition and Tuberous Sclerosis Prevention
по: J Gordon Millichap
Опубликовано: (2013-09-01)

Advances in the regulatory mechanisms of mTOR in necroptosis
по: Yawen Xie, и др.
Опубликовано: (2023-12-01)

Roles of mTOR in Diabetic Kidney Disease
по: Mako Yasuda-Yamahara, и др.
Опубликовано: (2021-02-01)